Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
08/2008
08/28/2008US20080207598 Indole derivatives
08/28/2008US20080207590 Inhibitors of Histone Deacetylase
08/21/2008WO2008099022A1 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008US20080200456 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine
08/21/2008US20080200455 1-Aryl- or 1-Alkylsulfonyl-Heterocyclylbenzazoles As 5-Hydroxytryptamine-6 Ligands
08/21/2008US20080199940 Cosmids; vectors; prokaryotics; Micromonospora biosynthesis
08/20/2008EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/19/2008US7414049 gamma -secretase inhibitors; treating Alzheimer's disease by blocking the activity of gamma -secretase and reducing or preventing the formation of the various amyloidogenic Abeta peptides; good thermodynamic solubility and bioavailability
08/14/2008US20080194546 wherein: one or two of X5, X6 and X8 is N, and the others are CH; R7 is selected from halo, ORO1, SRS1, NRN1RN2, NRN7aC( .dbd. O)RC1, NRN7bSO2RS2a, an optionally substituted C5-20 heteroaryl group, or an optionally substituted C5-20 aryl group, where RO1 and RS1 are selected from H,
08/14/2008US20080194520 Sulfonyl Amino Cyclic Derivatives and Use Thereof
08/13/2008CN101239953A Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
08/12/2008US7410963 Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
08/12/2008CA2304568C Olanzapine pamoate formulations
08/07/2008WO2007126935A3 Diazepan orexin receptor antagonists
08/07/2008US20080188465 Stable pure anhydrous polymorphic Form I, free of other polymorphs and solvating agents such as water and organic solvents; anti-psychotic agent
08/07/2008US20080188462 reversed chloroquines; to treat chloroquine resistant/sensitive malaria parasites; N'-(7-Chloro-quinolin-4-yl)-N-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-N-methyl-propane-1,3-diamine
08/06/2008EP1951249A2 Tyrosine kinase inhibitors
08/06/2008EP1951205A2 Stable composition for a pharmaceutical formulation containing olanzapine
07/2008
07/31/2008US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine
07/30/2008EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors
07/30/2008CN101233117A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
07/30/2008CN100406007C Asthma and allergic inflammation modulators
07/29/2008CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
07/29/2008CA2175767C Adhesion receptor antagonists
07/24/2008WO2008055068A8 Inhibitors of histone deacetylase
07/24/2008US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability
07/24/2008US20080176830 Compounds, Compositions, and Methods
07/23/2008CN100404535C Organic compounds as agents for the treatment of aldosterone mediated conditions
07/17/2008US20080171737 Cyclic sulfonamide derivatives and methods of their use
07/17/2008US20080171735 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
07/16/2008EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
07/16/2008EP1326849B1 Benzodiazepine derivatives as inhibitors of gamma secretase
07/15/2008CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors
07/10/2008WO2008082887A2 Inhibitors of poly(adp-ribose)polymerase
07/10/2008WO2008008884A3 Inhibition of beta-amyloid peptide aggregation
07/10/2008US20080167289 Pyrimidinohydrodiazepinones, e.g., 2-(1,6-dihydro-4-methyl-6-oxopyridin-3-ylamino)-9-cyclopentyl-8,9-dihydro-5,7,7-trimethyl-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one; especially c-Met kinase inhibitors; anticancer agents
07/10/2008CA2672860A1 Inhibitors of poly(adp-ribose)polymerase
07/09/2008EP1940805A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/03/2008US20080161294 Urea derivative, medicinal composition containing the same, and medicinal use of these
07/03/2008US20080161292 Inhibitors of poly(adp-ribose)polymerase
07/03/2008US20080161291 Antineoplastic agents
07/03/2008US20080161290 Serine hydrolase inhibitors
07/03/2008US20080161281 Amino-Substituted Tricyclic Derivatives and Methods of Use
07/02/2008EP1937252A2 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
07/02/2008EP1730117A4 Thiourea compositions and uses thereof
07/01/2008US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects
06/2008
06/26/2008WO2008002820A3 Substituted benzyl amine compounds
06/26/2008US20080153899 Fatty amine drug conjugates
06/26/2008US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/26/2008US20080153814 8-Chloro-2,3-Benzodiazepine Derivatives
06/26/2008US20080153812 Novel compounds
06/25/2008EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues.
06/24/2008US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide
06/24/2008US7390802 Substituted lactams as inhibitors of Aβ protein production
06/24/2008US7390801 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
06/24/2008US7390800 from a soil; 1,3-diazepine-4-one; antibacterial and anticarcinogenic agent; use for ATP synthesis; low toxicity; micromolecule compound
06/24/2008US7390797 Fused indazole compounds
06/19/2008US20080146547 e.g. 4-Chloro-1-hydroxy-phthalazine-6-carboxylic acid [4-chloro-3'-(2-dimethylamino-ethoxy)-biphenyl-3-yl]-amide; multifunctioning protein kinase inhibitors; anticarcinogenic, antiinflammatory, antidiabetic agent, neurodegenerative diseases
06/18/2008EP1931647A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
06/18/2008EP1931646A2 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs
06/18/2008EP1931347A2 Piperazine derivatives
06/18/2008EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
06/18/2008CN101203500A Substituted arylamine compounds and uses as 5-HT6 moderator thereof
06/17/2008CA2367704C Pyrazolobenzodiazepines as cdk2 inhibitors
06/12/2008US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/12/2008US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
06/12/2008US20080139536 Benzodiazepines for Treating or Preventing Rsv Infection
06/12/2008US20080139535 1-(2-naphthylsulfonyl)-4-(5-hydroxyaminocarbonylthiazol-2-yl)piperazine; antiproliferative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype;
06/11/2008EP1928845A2 Aminodiazepines as toll-like receptor modulators
06/11/2008EP1928465A1 Benzodiazepine derivatives for treating hepatitis c infection
06/10/2008US7384935 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals
06/05/2008US20080132490 1-heteroaryl-4-benzoyl-5-(alkyl or cycloalkyl)-1,4-diazepanes; sleep disorders, analgesics, obesity, Parkinson's disease, psychosis and schizophrenia; 6-fluoro-2-{(5R)-5-methyl-4-[2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl}quinazoline for example
06/05/2008US20080132489 1-aryl-alkyl-substituted-1,4-diazepine derivatives; 1-(4-Chloro-3-methoxy-phenyl)-3,3,5,5-tetramethyl-[1,4]diazepane for example; antidepressants, analgesics, various psychological disorders, dementia, eating disorders, drug abuse; side effect reduction
06/05/2008US20080132482 3-(2(R)-Cyclopentylmethyl-3 (S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one; neurological disorders related to beta -amyloid production, Alzheimer's disease, Down's Syndrome
06/05/2008US20080131943 Polynucleotides for production of farnesyl dibenzodiazepinones
06/05/2008DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent
05/2008
05/29/2008US20080125413 Antagonist for calcitonin gene related peptide (Cgrp); azepinone ligands; migranes; headaches; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
05/29/2008US20080125412 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes.
05/28/2008EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects
05/27/2008US7378411 Substituted thienopyrimidinones as a mitotic kinesin inhibitor
05/22/2008WO2008061108A2 Phthalazine derivatives
05/21/2008CN101184758A Novel compounds
05/20/2008US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis
05/20/2008US7375099 Malonamide derivatives
05/15/2008US20080114000 Suppressor of excess accumulation of intracellular sodium ions
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/14/2008EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/13/2008US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
05/08/2008WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
05/08/2008WO2008052638A1 DIAZEPANE-ACETAMIDE DERIVATIVES AS SELECTIVE 11β-HSD1 INHIBITORS
05/08/2008WO2008034735A3 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives
05/08/2008US20080108605 Anxiolytic agents with reduced sedative and ataxic effects
05/08/2008US20080108601 anticancer agents; catalytic hydrogenation
05/08/2008CA2668504A1 Diazepane-acetamide derivatives as selective 11.beta.-hsd1 inhibitors
05/08/2008CA2667826A1 Inhibitors of histone deacetylase
05/07/2008EP1918285A1 Diazepane-acetamide derivatives as selective 11beta-HSD1 inhibitors
05/07/2008EP1918272A1 Pharmaceutically active compounds and methods of use
05/07/2008EP1917012A1 Cell migration modulating compounds
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 60